Status
Conditions
Treatments
About
The quality of the intensive care unit (ICU) has been steadily improving over the years. Although improvements in the acute treatment of critically ill patients have been made, a large number of ICU survivors suffer from severe physical, cognitive and mental health problems persisting months to years after leaving the ICU. Physical impairments occur the most and can be very severe, greatly affecting activities in daily life and subsequently the perceived quality of life of ICU survivors. Although there is an increased awareness of long-term complaints following ICU stay, there is currently a knowledge gap on how to enhance the recovery of ICU survivors 6 to 12 months post-ICU discharge. The overall objective of the current study is to establish the extent of health and functional improvements that can be obtained with an optimized, combined exercise and nutritional intervention in ICU survivors 6 to 12 months post-ICU discharge.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Any medical condition that may interfere with the safety of the subjects during exercise or any condition that interferes with assessment of the outcome parameters, in the investigators' judgement in consultation with the responsible physician or treating physician/specialist. In case of a contra-indication for MRI (e.g., a pacemaker), subjects will be excluded from this measurement but not necessarily from the study.
Any medical condition or circumstance where supplementation with the nutritional supplement is potentially contra-indicated.
Known allergy to any of the ingredients present in the nutritional supplement.
Simultaneous use of other nutritional supplements during the study period (i.e., unwillingness to stop for the duration of the study).
Current participation in other scientific research that conflicts with this study (e.g. intervention studies or weight management studies).
No permission to request information from the general practitioner/treating specialist(s) about medical history, medication use.
Primary purpose
Allocation
Interventional model
Masking
35 participants in 1 patient group
Loading...
Central trial contact
Bram AJM Sauvé; Lex B Verdijk, Dr.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal